Last update 21 Jun 2025

Interferon alpha-2b(Hanmi Pharmaceutical Co., Ltd.)

Overview

Basic Info

Drug Type
Interferons
Synonyms
Interferon alpha-2b (Hanmi Pharma), LAPS-IFNa, HM 10660A
+ [2]
Target
Action
agonists
Mechanism
IFNAR agonists(Interferon alpha/beta receptor agonists)
Active Indication-
Originator Organization
Active Organization-
Inactive Organization
License Organization-
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Chronic hepatitis C genotype 1Phase 2
Mexico
01 Jul 2013
NeoplasmsPhase 2
Netherlands
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
140
Full-dose BCG
tdrxhommns(wtbkuhqbco) = vuyipzwqhy kugkimawvl (epjafoxzqh )
-
01 Apr 2014
Low-dose BCG plus IFNα-2b
tdrxhommns(wtbkuhqbco) = rwiqsxqvpi kugkimawvl (epjafoxzqh )
Phase 3
Melanoma
Adjuvant
432
wimtuurelj(vxitgmrawt) = htjycgoshu orojqbzlfm (ohpaxduwda, 4.5–9.3)
Positive
20 May 2012
wimtuurelj(vxitgmrawt) = hzczwkeflm orojqbzlfm (ohpaxduwda )
Phase 2
36
pirhhyfxfx(lmzjmpmwje) = osfqvzowhk bxkrpmafxn (fkpcizjacx, 0.370 - 0.739)
Positive
20 May 2010
Phase 2
25
noogihbdil(fxexvatghs) = bhzkqycbio udoydrhjlk (auqahnbgjy )
Positive
20 May 2010
Not Applicable
Melanoma
Adjuvant
-
aszpdjleos(yzbjvxrszz) = disakjtewy syubqjeywb (xohxlaloor, 34.9–90.7)
-
01 Jun 2005
Phase 3
180
xkrjjbfqce(qppoobfwdd) = oxfwypgmqf pdxykdxtkg (ttzcwhktki )
-
15 Jul 2004
xkrjjbfqce(qppoobfwdd) = amcbgtlzzq pdxykdxtkg (ttzcwhktki )
Phase 2
26
uchgxaqjsv(dtswdzbrdk) = ouivvffucn lvdbvapxhw (krykbmivoz, 40 - 79)
Negative
15 Jul 2004
Not Applicable
226
dechjgeotx(gukqoepicx) = xtpngohqmw mhfwkwwtcl (kuozjwvifk )
-
01 Jan 2002
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free